Preventing deaths after prison release

Telling the story of the opioid crisis: A narrative analysis of the TV series Dopesick

Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration

Epigenome-wide association study on methamphetamine dependence.

Disposable E-Cigarette Use and Subsequent Use Patterns in Adolescents and Young Adults

THE ASAM CRITERIA FOURTH EDITION.

As an addiction psychiatrist and community psychiatrist I have worked on improving integrated systems and services for 40 years. Most recently, I helped to develop the updated standards in the 4th Edition of The ASAM Criteria that encourage all addiction treatment programs to be co-occurring capable, at minimum. (See Chapter 12: Integrating Care for Co-occurring Mental Health Conditions.)

Association of Cannabis Use With Cardiovascular Outcomes Among US Adults

Racial and Ethnic Disparities in Geographic Availability of Buprenorphine

Are Headlines, Crises, and the Innocence of Youth Distracting Us from the Realities of Addiction Later in Life?

The question was simple: Do people still smoke cigarettes? They asked because none of their friends or family smoked, they didn’t see people do it in public, and they hadn’t seen a cigarette butt since the 90s.

Overdose mortality incidence and supervised consumption services

Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancy

Bringing Racial Justice to US Drug Policy Promotes Equity and Access to Addiction Treatment

Right now in the US, a Black man is living with the disease of addiction after being released from prison for possession of cocaine (for which there has long been a racist sentencing disparity between its rock and powder forms). Chances are, he did not receive evidence-based addiction treatment while incarcerated. Furthermore, notwithstanding the physical and emotional trauma he likely endured while in prison, he returns to the community without any resources to secure housing, health care, or employment.

First Trimester Use of Buprenorphine or Methadone.

History Repeats Itself - Trends in hallucinogen-associated emergency department visits and hospitalizations.

After more than two decades as a practicing psychiatrist, I’ll be the first to admit that we need new and innovative treatments to treat depression, anxiety, and other psychiatric disorders. Psychedelics like LSD, psilocybin, and MDMA (Ecstasy) are being researched and promoted as ground-breaking advances for combatting mental illness. Multiple jurisdictions have already relaxed laws or policies related to these substances, often with an eye toward therapeutic use.

Adolescent Residential Addiction Treatment In The US.

Several of our publications this week address the economics of addiction - supply, demand, and resources.